Your browser doesn't support javascript.
loading
Advances in HIV microbicide development.
Olsen, Joanna S; Easterhoff, David; Dewhurst, Stephen.
Afiliação
  • Olsen JS; Department of Microbiology & Immunology, University of Rochester, Rochester, NY 14627, USA.
Future Med Chem ; 3(16): 2101-16, 2011 Dec.
Article em En | MEDLINE | ID: mdl-22098355
ABSTRACT
There is an urgent need control the spread of the global HIV pandemic. A microbicide, or topical drug applied to the mucosal environment to block transmission, is a promising HIV prevention strategy. The development of a safe and efficacious microbicide requires a thorough understanding of the mucosal environment and its role in HIV transmission. Knowledge of the key events in viral infection identifies points at which the virus might be most effectively targeted by a microbicide. The cervicovaginal and rectal mucosa play an important role in the innate defense against HIV, and microbicides must not interfere with these functions. In this review, we discuss the current research on HIV microbicide development.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV Limite: Humans Idioma: En Ano de publicação: 2011 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV Limite: Humans Idioma: En Ano de publicação: 2011 Tipo de documento: Article